Latest filing published 02 Mar 2021 for GlaxoSmithKline plc.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
B McNamara: trading record in brief
This profile gathers the share dealings of B McNamara in GlaxoSmithKline plc. Between 13 October 2016 and 1 March 2021, the trades on record add up to 83 filings.
Market trades split into 1 purchase (€163k) and 3 sales (€1.1M). The amount is not disclosed for 1 filing. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 78 share grants.
Most recently, on 2 March 2021, the filings show a share grant in GlaxoSmithKline plc. The last insider purchase was made public on 15 March 2017, 3,524 days ago. Filings reach the RNS (LSE) feed a median of 2 days after the trade. The legal deadline for notifying a trade is three business days (UK MAR). Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
Companies and markets linked to B McNamara
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,346 shares0N/AISIN US37733W1053FCA-NSM:3897443-6
- 3,756 shares@ US$33.797N/AISIN US37733W1053FCA-NSM:3897443-7
- 43,024 shares@ US$35.6978New York Stock Exchange (XNYS)ISIN US37733W1053FCA-NSM:3882407-7
- 84,162 shares0N/AISIN US37733W1053FCA-NSM:3879317-8
- 7,442 shares@ US$35.75N/AISIN US37733W1053FCA-NSM:3878373-8
- 118,097 shares@ US$35.75N/AISIN US37733W1053FCA-NSM:3878367-9
- 1,119.805 shares@ US$38.5819New York Stock Exchange (XNYS)ISIN US37733W1053FCA-NSM:3851978-1
- 264 shares@ US$38.16New York Stock Exchange (XNYS)ISIN US37733W1053FCA-NSM:3851939-9
- 255 shares@ US$37.16New York Stock Exchange (XNYS)ISIN US37733W1053FCA-NSM:3748390-9
- 1,077.955 shares@ US$37.7256New York Stock Exchange (XNYS)ISIN US37733W1053FCA-NSM:3746934-8
- 222 shares@ US$40.3718.8% of flowNew York Stock Exchange (XNYS)ISIN US37733W1053FCA-NSM:3657059-9
- 963.868 shares@ US$40.072381.2% of flowNew York Stock Exchange (XNYS)ISIN US37733W1053FCA-NSM:3656063-8
- 1,131.33 shares@ US$38.8036New York Stock Exchange (XNYS)ISIN US37733W1053FCA-NSM:3564652-10
- 274 shares@ US$38.88New York Stock Exchange (XNYS)ISIN US37733W1053FCA-NSM:3564578-9
- 1,614 shares0N/AISIN US37733W1053FCA-NSM:LSE20200318122015_3531795_20200402163213738-0
- 825 shares@ US$33.420.4% of flowNew York Stock Exchange (XNYS)ISIN US37733W1053FCA-NSM:LSE20200318122015_3531795_20200402163213738-1
- 33,055 shares@ US$43.54423.4% of flowNew York Stock Exchange (XNYS)ISIN US37733W1053FCA-NSM:LSE20200220153005_3500898_20200331164942585_19927-6
- 5,890 shares@ US$43.5444.2% of flowNew York Stock Exchange (XNYS)ISIN US37733W1053FCA-NSM:LSE20200220140002_3500806_20200331164942559_19720-6
- 64,736 shares0N/AISIN US37733W1053FCA-NSM:LSE20200219163501_3499502_20200331164942435_18546-6
- 94,545 shares@ US$43.7867.3% of flowN/AISIN US37733W1053FCA-NSM:LSE20200219162845_3499497_20200331164942435_18543-9
- 11,861 shares0N/AISIN US37733W1053FCA-NSM:LSE20200219162412_3499487_20200331164942434_18535-3
- 5,626 shares@ US$43.784.0% of flowN/AISIN US37733W1053FCA-NSM:LSE20200219161740_3499482_20200331164942434_18534-8
- 214 shares@ US$46.650.0% of flowNew York Stock Exchange (XNYS)ISIN US37733W1053FCA-NSM:LSE20200115070004_14384225_20200331164952131_13473-7
- 24.753 shares@ US$47.0820.0% of flowNew York Stock Exchange (XNYS)ISIN US37733W1053FCA-NSM:LSE20200114164603_14383919_20200331164952115_13144
- 681.093 shares@ US$47.08190.1% of flowNew York Stock Exchange (XNYS)ISIN US37733W1053FCA-NSM:LSE20200114160113_14383885_20200331164952113_13117-9
25 of 83 declarations